Camarda Financial Advisors’s Acceleron Pharma XLRN Stock Holding History

Camarda Financial Advisors’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,433	Closed	-$419K	–	116
2021 Q3	$419K	Buy	+2,433	New	+$318K	0.28%	69
2016 Q3	–	Sell	-500	Closed	-$17K	–	265
2016 Q2	$17K	Hold	500	–	–	0.01%	185
2016 Q1	$13K	Buy	+500	New	+$14.5K	0.01%	191

Camarda Financial Advisors's XLRN Position: Q4 2021 in Review

Camarda Financial Advisors sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 2,433 shares — an estimated $419K sold.

Camarda Financial Advisors first reported a position in XLRN in Q1 2016 and held it in 3 quarters. The position peaked at $419K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Camarda Financial Advisors reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Camarda Financial Advisors sold 2,433 Acceleron Pharma shares in Q4 2021, an estimated $419K.
Camarda Financial Advisors first reported a position in Acceleron Pharma in Q1 2016 and held it in 3 quarters.
Camarda Financial Advisors's Acceleron Pharma position peaked at $419K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Camarda Financial Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.